New oxysterol based LXR-modulators have been synthesized. Importance of the 22th position of the oxysterol scaffold has been investigated. Compounds were evaluated in silico and in vitro for regulation of key LXR-target genes. 22-Ketocholesterol downregulates ABCA1 selectively. A new oxysterol analog was found to reduce lipogenesis.